AstraZeneca and Amgen secure FDA breakthrough designation for asthma drug tezepelumab

In a significant advancement for asthma treatment, AstraZeneca, in partnership with Amgen, has received the coveted breakthrough therapy designation from the US Food and Drug ... Read More